IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vertex Pharmaceuticals

CUSIP: 92532F106 | 1 institutional holders

Quarters

Q3 2024Q2 2024Q1 2024Q4 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2024

Columbia Asset Management599
0.0% of portfolio›$279
StyleTurnoverLocationFiled
Columbia Asset Management
599$2790.0%CoreLowAnn Arbor, MI2024-11-12